These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4229045)

  • 21. MOLECULAR CHANGES IN THE ACTIVATION OF PLASMINOGEN. II. COMPARISON OF PEPTIDE LIBERATION DURING INCUBATION WITH AND WITHOUT STREPTOKINASE.
    RIFE U; SHULMAN S
    Biochim Biophys Acta; 1964 May; 86():328-38. PubMed ID: 14171007
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of trypsin on the fibrinolytic system of normal serum treated with plasmin or streptokinase].
    GIACOMAZZI G
    Haematologica; 1962; 47():875-906. PubMed ID: 13947574
    [No Abstract]   [Full Text] [Related]  

  • 23. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 24. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
    GIBELLI A
    Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688
    [No Abstract]   [Full Text] [Related]  

  • 25. MOLECULAR CHANGES IN THE ACTIVATION OF PLASMINOGEN. I. THE RELEASE OF PEPTIDE FRAGMENTS.
    SHULMAN S; RIFE U
    Biochim Biophys Acta; 1964 May; 86():317-27. PubMed ID: 14171006
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of guanidine compounds on the activation of human plasminogen by streptokinase and on the rates of hydrolysis of p-toluenesulfonyl-L-arginine methyl ester by plasmin and activator.
    Roberts PS; Burkat RK
    Biochim Biophys Acta; 1966 Jun; 118(3):592-603. PubMed ID: 4226322
    [No Abstract]   [Full Text] [Related]  

  • 27. Standardization of fibrinolytic preparations. Measurement of proteolytic and activator activity of streptokinase-activated human plasminogen.
    BAUMGARTEN W; CIMINERA JL; VAN PELT SM
    J Pharm Sci; 1962 Apr; 51():314-7. PubMed ID: 13865955
    [No Abstract]   [Full Text] [Related]  

  • 28. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of glycerolmedium on the activation of human plasminogen by streptokinase and on the action of the enzyme, plasmin.
    ROBERTS PS
    Can J Biochem Physiol; 1962 Sep; 40():1203-12. PubMed ID: 14492785
    [No Abstract]   [Full Text] [Related]  

  • 30. Formation and properties of the activator of plasminogen and of human and bovine plasmin.
    MULLERTZ S
    Biochem J; 1955 Nov; 61(3):424-34. PubMed ID: 13269378
    [No Abstract]   [Full Text] [Related]  

  • 31. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN.
    NILSSON IM; BIELAWIEC M; BJOERKMAN SE
    Scand J Haematol; 1964; 1():75-88. PubMed ID: 14175721
    [No Abstract]   [Full Text] [Related]  

  • 32. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 33. PREPARATION, STABILIZATION AND SOME PROPERTIES OF PURIFIED HUMAN PLASMIN.
    KLINE DL; FISHMAN JB
    Thromb Diath Haemorrh; 1964 Apr; 11():75-84. PubMed ID: 14167117
    [No Abstract]   [Full Text] [Related]  

  • 34. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 35. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.
    HECKER SP
    Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.
    BLIX S
    Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of certain phospholipids on plasminogen activation and plasmin activity.
    GERBECK C; KOPPEL JL; OLWIN JH
    Thromb Diath Haemorrh; 1962 Mar; 7():16-26. PubMed ID: 13897885
    [No Abstract]   [Full Text] [Related]  

  • 38. [A quick photometric method for the determination of activable plasminogen and of plasmin].
    Bouvier CA; Berthoud S; Roth M
    Thromb Diath Haemorrh; 1967 May; 17(3-4):452-66. PubMed ID: 4231950
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of streptokinase and human plasminogen. 3. Plasmin and activator activities in reaction mixtures of streptokinase and human plasminogen or human plasmin of various molar ratios.
    Hummel BC; Buck FF; De Renzo EC
    J Biol Chem; 1966 Aug; 241(15):3474-9. PubMed ID: 4224092
    [No Abstract]   [Full Text] [Related]  

  • 40. [USE OF PLASMIN IN CRURAL ULCER].
    UHRIK J; STEPANEK I
    Cesk Dermatol; 1964 Jul; 39():261-3. PubMed ID: 14180129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.